Evotec SE (OTCMKTS:EVTCY – Get Free Report) hit a new 52-week low on Monday . The company traded as low as $3.48 and last traded at $3.50, with a volume of 21300 shares trading hands. The stock had previously closed at $3.54.
Evotec Price Performance
The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The stock has a market cap of $1.20 billion, a PE ratio of 8.88 and a beta of 0.98. The company has a fifty day moving average of $3.91 and a 200-day moving average of $5.22.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
- Five stocks we like better than Evotec
- Ride Out The Recession With These Dividend Kings
- How Much Can You Make in Stocks in One Month?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- This Is the Top Large-Cap Stock Insiders Are Buying
- Retail Stocks Investing, Explained
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
